This inventor holds 10 USPTO granted patents. Top assignees: Zeneca Limited, Astra Zeneca U.k. Limited, Astrazeneca Ab. Active years: 1995-2008.
Location History:
- Macclesfield, Cheshire, SK10 4TG, GB (2002)
- Stockport, GB (1995 - 2008)
- Cheshire, GB (1997 - 2008)
Company Filing History:
6 out of 854 
2 out of 110 
1 out of 1,531 
Years Active: 1995-2008
Title: Michael Lingard Swain: Innovator in Antibacterial Agents
Introduction
Michael Lingard Swain is a notable inventor based in Stockport, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial agents. With a total of 10 patents to his name, Swain's work has had a considerable impact on medical science.
Latest Patents
Swain's latest patents include innovative compounds such as oxazolidinone and isoxazoline, which are recognized for their antibacterial properties. These compounds are described by specific formulas, including pharmaceutically acceptable salts and in-vivo-hydrolysable esters. His research also encompasses antibiotic compounds related to carbapenems, showcasing his commitment to advancing medical treatments.
Career Highlights
Throughout his career, Swain has worked with prominent companies in the pharmaceutical industry, including Zeneca Limited and AstraZeneca UK Limited. His experience in these organizations has allowed him to develop and refine his inventions, contributing to the advancement of healthcare solutions.
Collaborations
Swain has collaborated with notable colleagues such as Michael John Betts and Gareth Morse Davies. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his work.
Conclusion
Michael Lingard Swain's contributions to the field of antibacterial agents through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in pharmaceutical science.